iSpecimen Inc.
ISPC
$2.55
-$0.08-3.04%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Revenue | 1.03M | 1.93M | 3.35M | 5.91M | 8.06M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 1.03M | 1.93M | 3.35M | 5.91M | 8.06M |
| Cost of Revenue | 1.33M | 1.90M | 2.63M | 3.98M | 4.96M |
| Gross Profit | -304.50K | 24.10K | 722.60K | 1.93M | 3.10M |
| SG&A Expenses | 7.71M | 6.84M | 10.27M | 10.15M | 11.30M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 10.91M | 10.91M | 15.48M | 16.91M | 19.42M |
| Operating Income | -9.88M | -8.98M | -12.13M | -11.01M | -11.37M |
| Income Before Tax | -11.10M | -10.49M | -11.53M | -10.19M | -11.25M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -11.10 | -10.49 | -11.53 | -10.19 | -11.25 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -11.10M | -10.49M | -11.53M | -10.19M | -11.25M |
| EBIT | -9.88M | -8.98M | -12.13M | -11.01M | -11.37M |
| EBITDA | -9.68M | -8.72M | -11.87M | -10.75M | -11.11M |
| EPS Basic | -68.43 | -90.32 | -278.17 | -342.94 | -474.94 |
| Normalized Basic EPS | -42.77 | -56.45 | -173.86 | -214.34 | -296.84 |
| EPS Diluted | -68.43 | -90.32 | -278.17 | -342.94 | -474.94 |
| Normalized Diluted EPS | -42.77 | -56.45 | -173.86 | -214.34 | -296.84 |
| Average Basic Shares Outstanding | 742.60K | 459.30K | 294.80K | 166.00K | 117.80K |
| Average Diluted Shares Outstanding | 742.60K | 459.30K | 294.80K | 166.00K | 117.80K |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |